Drug-Eluting Technologies in Peripheral Arterial Disease With a Focus on Chronic Limb-Threatening Ischemia
Journal of Critical Limb Ischemia · 2026-06 · 6 (2) · E36-E45
DOI: 10.25270/jcli/clig-2500009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Critical Limb Ischemia, 2026-06. Verfasst von Matthew Finn und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Drug-coated technologies target the delivery of therapeutics directly to specific vascular segments with or without relying on a permanent scaffold. Paclitaxel remains the predominantly utilized antirestenotic medication in peripheral arterial treatment. This review provides a detailed discussion of research evaluating paclitaxel and alternative drug-coated therapies within the context of contemporary treatment of chronic limb-threatening ischemia.
Zitieren
APA
Finn, M., Yazdani, S., Walker, M., Nakama, T., Abdelghany, M., Pruthi, S., Zilinyi, R., Snyder, D., N'Dandu, Z., Parikh, S., Walker, C., & Nair, P. (2026). Drug-Eluting Technologies in Peripheral Arterial Disease With a Focus on Chronic Limb-Threatening Ischemia. Journal of Critical Limb Ischemia, 6(2), E36-E45. https://doi.org/10.25270/jcli/clig-2500009
Vancouver
Finn M, Yazdani S, Walker M, Nakama T, Abdelghany M, Pruthi S, et al. Drug-Eluting Technologies in Peripheral Arterial Disease With a Focus on Chronic Limb-Threatening Ischemia. Journal of Critical Limb Ischemia. 2026;6(2):E36-E45. doi:10.25270/jcli/clig-2500009
BibTeX
@article{Finn2026,
author = {Finn, Matthew and Yazdani, Saami and Walker, McCall and Nakama, Tatsuya and Abdelghany, Mahmoud and Pruthi, Sonal and Zilinyi, Robert and Snyder, Daniel and N'Dandu, Zola and Parikh, Sahil and Walker, Craig and Nair, Pradeep},
title = {Drug-Eluting Technologies in Peripheral Arterial Disease With a Focus on Chronic Limb-Threatening Ischemia},
journal = {Journal of Critical Limb Ischemia},
year = {2026},
volume = {6},
number = {2},
pages = {E36--E45},
doi = {10.25270/jcli/clig-2500009}
}
EUVIMED